RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$11.02
−1.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 378.64x
- P/S forward
- 3.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -12.24x
- Price / sales
- 4.51x
- Price / cash flow
- -14.07x
Enterprise value
- Enterprise value
- $378.2M
- EV / sales
- 5.00x
- EV / EBITDA
- -10.99x
- EV / EBIT
- -10.74x
- Market cap
- $340.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026